Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib plus letrozole for hormone receptor-positive ovarian cancer
RBR-8k2928Phase 2Not yet recruiting
- Sponsor
- Latin American Cooperative Oncology Group
- Start
- Dec 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of palbociclib and letrozole in ovarian cancer (2 arms), sponsored by Latin American Cooperative Oncology Group. Planned start Dec 2019; status: not yet recruiting.
02
Drugs
palbociclibletrozole
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on RBR-8k2928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8k2928.